| News
DayOne Tech supports three medtech startups
18.08.2022
DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of Jura with three startups. CNS Therapy, Moonlight AI, and CryoThermo 4.0 will receive access to coaching, the ecosystem, office space, and funds over twelve months.

Three medtech startups began their year-long journey through DayOne Tech’s acceleration program in the canton of Jura on August 17. According to a press release, they are CNS Therapy, Moonlight AI, and CryoThermo 4.0. They will gain access to coaching, the ecosystem, office space, and funds. The healthcare innovation initiative from Basel Area Business & Innovation, an investment and innovation promotion agency, brings together professionals and specialists from various disciplines and companies in the Basel Area to strengthen the healthcare ecosystem and make it more sustainable.
Three startups selected
CNS Therapy from Zug has developed a treatment for chronic pain without medication, surgery, or implants. Its systolic extinction therapy, for example, using neuromodulation and behavioral therapy has been proven effective in randomized studies. It is an innovative, interactive behavioral therapy combined with a patented medical device.
Moonlight AI with headquarters at the Switzerland Innovation Park Basel Area – Jura in Courroux in the Swiss canton of Jura develops artificial intelligence models to predict genomic biomarkers that are therapeutically relevant. It uses scans of stained hematology or pathology slides to do so. The startup aims to use these to democratize access to genomic information for therapeutic decisions.
CryoThermo 4.0 is developing a new generation of patented medical thermal compresses “thanks to a technological and therapeutic paradigm shift”. The startup also plans to manufacture and market these. The aim is to become the global leader in this area.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read MoreBasel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read MoreRoche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...
Read MoreRoche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...
Read More